Bryn Mawr Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bryn Mawr Capital Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,999	Closed	-$306K	–	161
2021 Q4	$306K	Sell	4,999 -416	-8%	-$28.8K	0.12%	79
2021 Q3	$405K	Hold	5,415	–	–	0.18%	65
2021 Q2	$501K	Buy	5,415 +912	+20%	+$77.5K	0.23%	55
2021 Q1	$400K	Buy	+4,503	New	+$447K	0.2%	60

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bryn Mawr Capital Management's ARKG Position: Q1 2022 in Review

Bryn Mawr Capital Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 4,999 shares — an estimated $306K sold.

Bryn Mawr Capital Management first reported a position in ARKG in Q1 2021 and held it in 4 quarters. The position peaked at $501K in Q2 2021. 387 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

Bryn Mawr Capital Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
Bryn Mawr Capital Management sold 4,999 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $306K.
Bryn Mawr Capital Management first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 4 quarters.
Bryn Mawr Capital Management's ARK Genomic Revolution ETF position peaked at $501K in Q2 2021.
387 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Bryn Mawr Capital Management's 13F filing for Q1 2022, filed 13 May 2022.